BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Q, Wei S, Zhou H, Li L, Zhou S, Shi C, Shi Y, Qiu J, Lu L. MicroRNA-98 Inhibits Hepatic Stellate Cell Activation and Attenuates Liver Fibrosis by Regulating HLF Expression. Front Cell Dev Biol 2020;8:513. [PMID: 32637414 DOI: 10.3389/fcell.2020.00513] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Wu X, Dong W, Kong M, Ren H, Wang J, Shang L, Zhu Z, Zhu W, Shi X. Down-Regulation of CXXC5 De-Represses MYCL1 to Promote Hepatic Stellate Cell Activation. Front Cell Dev Biol 2021;9:680344. [PMID: 34621736 DOI: 10.3389/fcell.2021.680344] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Luo N, Li J, Wei Y, Lu J, Dong R. Hepatic Stellate Cell: A Double-Edged Sword in the Liver. Physiol Res 2021;70. [PMID: 34717063 DOI: 10.33549/physiolres.934755] [Reference Citation Analysis]
3 Sulaiman SA, Dorairaj V, Abdul Ghafar KN, Abdul Murad NA. Noncoding RNAs Interactions in Hepatic Stellate Cells during Hepatic Fibrosis. Livers 2021;1:263-85. [DOI: 10.3390/livers1040021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhang L, Wei Z, Wang Y, Xu F, Cheng Z. Long noncoding RNA ROR1-AS1 enhances STC2-mediated cell growth and autophagy in cervical cancer through miR-670-3p. Journal of Receptors and Signal Transduction. [DOI: 10.1080/10799893.2020.1836495] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Wang Y, Chen B, Xiao C, Yu J, Bu X, Jiang F, Ding W, Ge Z. Effect of miR-183-5p on Cholestatic Liver Fibrosis by Regulating Fork Head Box Protein O1 Expression. Front Physiol 2021;12:737313. [PMID: 34867446 DOI: 10.3389/fphys.2021.737313] [Reference Citation Analysis]
6 Xiang M, Liu T, Tian C, Ma K, Gou J, Huang R, Li S, Li Q, Xu C, Li L, Lee CH, Zhang Y. For the Topic - The New Therapeutic Approaches, Biomarkers and Molecular Mechanisms of Organ Fibrosis and COVID19 Rehabilitation Kinsenoside attenuates liver fibro-inflammation by suppressing dendritic cells via the PI3K-AKT-FoxO1 pathway. Pharmacol Res 2022;:106092. [PMID: 35066108 DOI: 10.1016/j.phrs.2022.106092] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Fan C, Ma Y, Chen S, Zhou Q, Jiang H, Zhang J, Wu F. Comprehensive Analysis of the Transcriptome-Wide m6A Methylation Modification Difference in Liver Fibrosis Mice by High-Throughput m6A Sequencing. Front Cell Dev Biol 2021;9:767051. [PMID: 34869362 DOI: 10.3389/fcell.2021.767051] [Reference Citation Analysis]
8 Xue T, Qiu X, Liu H, Gan C, Tan Z, Xie Y, Wang Y, Ye T. Epigenetic regulation in fibrosis progress. Pharmacol Res 2021;173:105910. [PMID: 34562602 DOI: 10.1016/j.phrs.2021.105910] [Reference Citation Analysis]
9 Zhao H, Feng YL, Liu T, Wang JJ, Yu J. MicroRNAs in organ fibrosis: From molecular mechanisms to potential therapeutic targets. Pathol Res Pract 2021;225:153588. [PMID: 34419718 DOI: 10.1016/j.prp.2021.153588] [Reference Citation Analysis]
10 Chen D, Cheung H, Lau HC, Yu J, Wong CC. N6-Methyladenosine RNA-Binding Protein YTHDF1 in Gastrointestinal Cancers: Function, Molecular Mechanism and Clinical Implication. Cancers 2022;14:3489. [DOI: 10.3390/cancers14143489] [Reference Citation Analysis]
11 Zhang J, Chen Y, Tian Y, Chen S, Liu H. Knockdown of TRIM15 inhibits the activation of hepatic stellate cells. J Mol Histol 2021;52:839-48. [PMID: 34142270 DOI: 10.1007/s10735-021-09997-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ezhilarasan D. MicroRNA interplay between hepatic stellate cell quiescence and activation. Eur J Pharmacol 2020;885:173507. [PMID: 32858048 DOI: 10.1016/j.ejphar.2020.173507] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
13 Du Y, Shi X, Li J, Jia Y. MicroRNA-98-5p inhibits human mesangial cell proliferation and TNF-α and IL-6 secretion by targeting BTB and CNC homology 1. Exp Ther Med 2021;22:1436. [PMID: 34721678 DOI: 10.3892/etm.2021.10871] [Reference Citation Analysis]
14 Cai J, Hu M, Chen Z, Ling Z. The roles and mechanisms of hypoxia in liver fibrosis. J Transl Med 2021;19:186. [PMID: 33933107 DOI: 10.1186/s12967-021-02854-x] [Reference Citation Analysis]
15 Chen L, Huang Y, Duan Z, Huang P, Yao H, Zhou Y, Ji Q, Liu X. Exosomal miR-500 Derived From Lipopolysaccharide-Treated Macrophage Accelerates Liver Fibrosis by Suppressing MFN2. Front Cell Dev Biol 2021;9:716209. [PMID: 34676206 DOI: 10.3389/fcell.2021.716209] [Reference Citation Analysis]
16 Baghaei K, Mazhari S, Tokhanbigli S, Parsamanesh G, Alavifard H, Schaafsma D, Ghavami S. Therapeutic potential of targeting regulatory mechanisms of hepatic stellate cell activation in liver fibrosis. Drug Discov Today 2021:S1359-6446(21)00562-6. [PMID: 34952225 DOI: 10.1016/j.drudis.2021.12.012] [Reference Citation Analysis]